Table 5 Kaplan-Meier survival curve estimates and 95% CIs at different time points, overall and stratified by race
From: Modelling attrition and nonparticipation in a longitudinal study of prostate cancer
| Â | Product-Limit Estimates of Participation in Wave 2 | ||
|---|---|---|---|
Time Since Wave 1 (Years) | Overall | AAa | EAa |
3.00 | 1.0 | 1.0 | 1.0 |
4.00 | 0.766 (0.740–0.789) | 0.682 (0.642–0.718) | 0.851 (0.819–0.877) |
4.64 | 0.500 (0.469–0.528) | 0.502 (0.458–0.544) | 0.507 (0.466–0.547) |
4.65 | 0.497 (0.467–0.526) | 0.500 (0.456–0.541) | 0.506 (0.464–0.545) |
4.66 | 0.493 (0.463–0.522) | 0.500 (0.456–0.541) | 0.500 (0.457–0.538) |
4.70 | 0.489 (0.459–0.519) | 0.499 (0.453–0.539) | 0.491 (0.450–0.531) |
5.00 | 0.441 (0.411–0.470) | 0.461 (0.417–0.504) | 0.434 (0.393–0.474) |
6.00 | 0.325 (0.294–0.356) | 0.363 (0.316–0.409) | 0.301 (0.261–0.343) |
7.00 | 0.203 (0.173–0.236) | 0.214 (0.169–0.262) | 0.203 (0.162–0.248) |
8.00 | 0.198 (0.167–0.230) | 0.204 (0.160–0.252) | 0.203 (0.162–0.248) |